Inconsistent alignment with WHO TRS during API sourcing – gap remediation roadmap



Published on 28/01/2026

Strategies for Bridging Gaps in API Sourcing Alignment with WHO TRS

Inconsistent alignment with WHO TRS during API sourcing can lead to quality discrepancies, regulatory failures, and potential disruptions in the supply chain. Pharmaceutical manufacturers face critical challenges when their processes for sourcing Active Pharmaceutical Ingredients (APIs) do not meet the rigorous standards set forth by international recommendations. This playbook aims to guide pharmaceutical professionals through actionable steps to identify, address, and prevent misalignments with WHO guidelines.

After implementing the strategies within this article, roles across Production, Quality Control (QC), Quality Assurance (QA), Engineering, and Regulatory Affairs (RA) will be equipped to effectively manage and remediate gaps in compliance with WHO GMP directives. This roadmap will enhance overall audit readiness and optimize quality management systems (QMS) for API sourcing.

Symptoms/Signals on the Floor or in the Lab

Identifying indicators of misalignment with WHO TRS during API sourcing

is critical to maintaining compliance. Common symptoms may manifest as:

  • Increased deviation reports: Frequent reports of non-conformities from production batches can signal potential sourcing issues.
  • Batch recalls: Recalls linked to the quality of APIs sourced may indicate systemic sourcing problems.
  • Inspection findings: Observations or citations from FDA, EMA, or MHRA inspections related to API quality can reveal compliance gaps.
  • Supply disruptions: Interruptions in the supply chain due to API quality can significantly impact production timelines.
  • Reduced yield or increased scrap: Low yields or excessive scrap rates during production often point to quality discrepancies in the sourced APIs.

Likely Causes

To effectively address the symptoms above, it is essential to categorize the potential causes of inconsistency in API sourcing:

Pharma Tip:  Documentation not aligned to WHO during API sourcing – CAPA aligned to WHO standards
Category Possible Causes
Materials Substandard API quality, inappropriate sourcing contracts.
Method Faulty sampling methods or testing protocols.
Machine Equipment malfunction affecting API handling.
Man Lack of training among staff related to WHO GMP standards.
Measurement Inaccurate measurement techniques for API characterization.
Environment Storage conditions not compliant with regulatory requirements.

Immediate Containment Actions

In the first 60 minutes following the identification of potential inconsistencies, the following containment actions should be enacted:

  1. Stop production: Immediately halt production processes using affected APIs.
  2. Isolate affected materials: Segregate any batch affected by the inconsistency to prevent further use.
  3. Notify stakeholders: Inform relevant stakeholders, including QA, RA, and production supervisors, about the incident.
  4. Begin preliminary analysis: Collect preliminary data regarding the incident, including lot numbers and affected batches.
  5. Communicate with suppliers: Reach out to API suppliers to gather information on quality control processes and recent audits.

Investigation Workflow

A structured investigation workflow is crucial for identifying the root causes of inconsistencies:

  • Data collection: Gather data from various sources including batch records, deviation reports, and supplier quality assessments.
  • Data interpretation: Analyze data for trends and patterns that point to a specific area of concern. Look for correlations between batch failures and API sources.
  • Interviews: Conduct interviews with personnel involved in sourcing and testing APIs; this can provide insights into any lapses in protocol.
  • Document findings: Ensure all findings are well-documented as they will inform corrective actions and future preventive measures.

Root Cause Tools

Employ various root cause analysis (RCA) tools to deeply assess the issues, focusing on the following methodologies:

  • 5-Why Analysis: Best used when a problem is complex but straightforward; consistently ask “why” to drill down to root causes.
  • Fishbone Diagram: Effective for identifying multiple contributing factors across categories (Man, Machine, Method, etc.).
  • Fault Tree Analysis: Useful for complex problems in systems with multiple failures; visually maps the pathways that can lead to failures.

CAPA Strategy

A robust Corrective and Preventive Action (CAPA) strategy is essential to address the root causes of identified issues:

  • Correction: Implement immediate fixes to correct identified non-conformities to restore operations.
  • Corrective Action: Develop and execute plans that address the root causes, such as revising supplier agreements or enhancing quality checks.
  • Preventive Action: Introduce controls to mitigate future occurrences, such as supplier qualification protocols or regular training programs for staff.
Pharma Tip:  Inadequate WHO GMP training during internal gap assessment – CAPA aligned to WHO standards

Control Strategy & Monitoring

Establishing a control strategy is vital for ensuring ongoing compliance and quality assurance:

  • Statistical Process Control (SPC): Implement SPC techniques to monitor critical parameters related to API quality, identifying variation trends early.
  • Sampling Plans: Create rigorous sampling plans that integrate batch testing and real-time analytics to assess API quality proactively.
  • Alarms and Alerts: Utilize real-time alerts for deviations from established quality parameters, allowing for timely interventions.
  • Verification Processes: Regularly verify suppliers’ compliance with quality expectations through audits and re-evaluations.

Validation / Re-qualification / Change Control Impact

Understanding the impact of finding gaps in sourcing alignment on validation and change control processes is crucial:

  • Validation: Re-evaluate and validate any processes or equipment impacted by the inconsistencies in API sourcing.
  • Re-qualification: If adjustments are made to the sourcing or packaging of APIs, re-qualify related processes to confirm compliance.
  • Change Control: Document any changes to suppliers or sourcing techniques in a controlled manner, following standard operating procedures.

Inspection Readiness: What Evidence to Show

To prepare for regulatory scrutiny, ensure that the following documentation is readily available:

  • Records: Maintain comprehensive records of all batches produced, including raw materials, quality tests, and deviations.
  • Logs: Keep meticulous logs of production processes to track any anomalies and their resolutions.
  • Batch Documentation: Ensure batch production records are complete and reflect compliance with WHO TRS guidelines.
  • Deviations: Document all deviations with thorough investigations and corrective actions for audit readiness.

FAQs

What are the potential impacts of API sourcing discrepancies?

API sourcing discrepancies can lead to product quality issues, regulatory citations, batch recalls, and loss of consumer trust.

Pharma Tip:  Inconsistent alignment with WHO TRS during WHO inspection – CAPA aligned to WHO standards

Related Reads

How can I ensure my suppliers meet WHO TRS standards?

Engage in regular audits, require documented evidence of compliance, and train supplier staff on WHO GMP standards.

What is the role of QC in managing API sourcing issues?

Quality Control monitors incoming API quality, conducts testing, and identifies deviations against established specifications.

How can statistical process control (SPC) aid in compliance?

SPC helps in monitoring processes in real-time, enabling timely interventions if parameters deviate from defined quality limits.

What documentation is essential for inspection readiness?

Key documents include batch records, quality control test results, audit trails, and CAPA reports.

When should a root cause analysis be initiated?

A root cause analysis should be initiated whenever a significant deviation or incident is identified that impacts API quality.

What training is necessary for employees involved in API sourcing?

Employees should receive training in WHO TRS guidelines, quality assurance principles, and good manufacturing practices.

How often should suppliers be audited for compliance?

Suppliers should be subject to periodic audits at least annually, or more frequently based on their risk profile or past issues.

What preventive actions are effective in managing API quality?

Preventive actions may include enhanced supplier assessments, continuous training programs, and stringent quality checks at various stages of sourcing.

How does validation relate to changes in sourcing strategies?

Changes in sourcing strategies must be validated to ensure that processes continue to meet quality standards post-implementation.

What is the importance of communication with suppliers?

Effective communication ensures clarity on quality expectations and fosters collaboration in quality improvement efforts.

Can regulatory authorities provide guidelines for compliance?

Regulatory authorities such as the FDA and EMA publish extensive guidelines to help manufacturers comply with quality standards.

Also Read